Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
PHARMASIMPLE Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
INNOCAN PHARMA | 0,111 | +1,84 % | Breaking News: Bestätigung: Paradigmenwechsel durch LPT-CBD von InnoCan Pharma!? | ||
SYNBIOTIC | 3,110 | -0,48 % | EQS-News: SYNBIOTIC SE: Erfolgreiche Roadshow geht weiter: SYNBIOTIC baut Präsenz in der Cannabis- und Hanfbranche kontinuierlich aus | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Konferenz/Stellungnahme
Erfolgreiche Roadshow geht weiter: SYNBIOTIC baut Präsenz in der Cannabis- und Hanfbranche kontinuierlich aus
11.06.2025... ► Artikel lesen | |
BIONANO GENOMICS | 3,650 | -0,82 % | Bionano Genomics, Inc. - 8-K, Current Report | ||
AXSOME THERAPEUTICS | 91,26 | +1,26 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia | NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today... ► Artikel lesen | |
JAGUAR HEALTH | 3,630 | -5,22 % | Jaguar Health, Inc.: First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs | Two parallel goals for Canalevia-CA1 (crofelemer delayed-release tablets): To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of crofelemer... ► Artikel lesen | |
GREENRISE GLOBAL BRANDS | 0,003 | 0,00 % | Greenrise Global Brands Inc: Greenrise files 2024 results, to file Q1 results | ||
TRULIEVE CANNABIS | 3,274 | +3,22 % | Trulieve Cannabis Corp. - 8-K, Current Report | ||
ENDO | - | - | Mallinckrodt plc: Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader | Mallinckrodt to Apply to Irish High Court for Approval of Scheme of Arrangement DUBLIN and MALVERN, Pa., June 13, 2025 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt") and Endo, Inc.... ► Artikel lesen | |
WEST PHARMACEUTICAL SERVICES | 195,05 | +1,54 % | Dividendenbekanntmachungen (30.04.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AG MORTGAGE INVESTMENT TRUST INC US0012285013 0,2 USD EUR ALLIED PROPERTIES REAL ESTATE INVESTMENT ... CA0194561027 0,15 CAD 0... ► Artikel lesen | |
KALA BIO | 3,780 | +1,61 % | KALA BIO, Inc.: KALA BIO Announces Chief Executive Officer Transition | ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative... ► Artikel lesen | |
SHIONOGI | 14,900 | -0,67 % | Shionogi-Aktie unter Druck: Kurs fällt um 4,76 Prozent (14,00 €) | Die Aktie von Shionogi zählt heute zu den großen Verlierern am Aktienmarkt. Das Wertpapier verbilligt sich am Montag deutlich. Ein Verlust von 4,76 Prozent zeigt die Kurstafel für das Wertpapier von... ► Artikel lesen | |
THERIVA BIOLOGICS | 0,495 | 0,00 % | Theriva Biologics, Inc.: Theriva Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Canc | - Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in a poster session at the American Society of Clinical Oncology... ► Artikel lesen | |
CHARLOTTES WEB | 0,067 | +0,76 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports Shareholder Meeting Voting Results | LOUISEVILLE, Colo., June 13, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce... ► Artikel lesen | |
BEXIMCO | 0,410 | -8,89 % | Beximco Pharma awaits High Court decision on BSEC director order |